Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Treasury Stock | Retained (Deficit) Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning Balance (in shares) at Dec. 31, 2019 | | 37,679,000 | | | | |
Beginning Balance at Dec. 31, 2019 | $ 175.5 | $ 0.4 | $ 189.7 | $ (20.4) | $ 2.8 | $ 3 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Stock-based compensation expense | 1 | | 1 | | | |
Issuance of restricted stock (in shares) | | 36,000 | | | | |
Issuance of restricted stock | 0 | | (0.6) | 0.6 | | |
Stock withheld for employee taxes (in shares) | | (15,000) | | | | |
Stock withheld for employee taxes | (0.3) | | | (0.3) | | |
Proceeds from issuance of common stock (in shares) | | 30,000 | | | | |
Proceeds from issuance of common stock | 0.3 | | (0.2) | 0.5 | | |
Issuance of shares under employee stock purchase plan (in shares) | | 23,000 | | | | |
Issuance of shares under employee stock purchase plan | 0.4 | | 0.4 | | | |
Dividends | $ (43.3) | | | | (43.3) | |
Purchase of treasury shares (in shares) | (233,249) | (233,000) | | | | |
Purchase of treasury shares | $ (3.9) | | | (3.9) | | |
Change in cumulative translation adjustment | (0.2) | | | | | (0.2) |
Net income | 8.2 | | | | 8.2 | |
Ending Balance (in shares) at Mar. 31, 2020 | | 37,520,000 | | | | |
Ending Balance at Mar. 31, 2020 | 137.7 | $ 0.4 | 190.3 | (23.5) | (32.3) | 2.8 |
Beginning Balance (in shares) at Dec. 31, 2020 | | 37,552,000 | | | | |
Beginning Balance at Dec. 31, 2020 | 106.8 | $ 0.4 | 193.5 | (24) | (66.5) | 3.4 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | |
Stock-based compensation expense | 0.4 | | 0.4 | | | |
Issuance of restricted stock (in shares) | | 65,000 | | | | |
Issuance of restricted stock | 0 | | (1.1) | 1.1 | | |
Stock withheld for employee taxes (in shares) | | (47,000) | | | | |
Stock withheld for employee taxes | (1.9) | | | (1.9) | | |
Proceeds from issuance of common stock (in shares) | | 119,000 | | | | |
Proceeds from issuance of common stock | 2.3 | | (0.2) | 2.5 | | |
Issuance of shares under employee stock purchase plan (in shares) | | 29,000 | | | | |
Issuance of shares under employee stock purchase plan | 0.5 | | 0.5 | | | |
Dividends | $ (6) | | | | (6) | |
Purchase of treasury shares (in shares) | 0 | | | | | |
Change in cumulative translation adjustment | $ 0.1 | | | | | 0.1 |
Net income | 15.2 | | | | 15.2 | |
Ending Balance (in shares) at Mar. 31, 2021 | | 37,718,000 | | | | |
Ending Balance at Mar. 31, 2021 | $ 117.4 | $ 0.4 | $ 193.1 | $ (22.3) | $ (57.3) | $ 3.5 |